Senesco Technologies, Inc.

Description

Ronald A. Martell has been our Chief Executive Officer since June 25, 2014. Mr. Martell has led successful companies in the biotech industry for over 25 years. Most recently, from January 2012 to July 2013, he served as the President, Director and Chief Executive Officer of NeurogesX, Inc., where he sold the company assets to Acorda Therapeutics. Read full biography .

About Senesco Technologies, Inc Senesco Technologies is a clinical-stage biotech company specializing in cancer therapeutics and immunological diseases driven by a unique combination of gene regulation and antibody therapeutics. Its proprietary gene regulation technology has demonstrated the ability to eliminate cancer cells and protect healthy cells from premature death.

Leslie J. Browne, Ph.D. has been our President since May 2010. Dr. Browne has also been Chief Executive Officer from May 2010 through May 2014. He had been our director from March 2011 through May 2014. Dr. Browne has over 30 years of experience in the pharmaceutical industry. Prior to joining Senesco in May 2010, he served from October 2008 to May 2010 as President and CEO, and is currently chair, of Phrixus Pharmaceuticals, Inc., a private biotech working on muscular dystrophy and heart failure.

Companies nearby